Clinical Diagnostics PCR Market
Clinical Diagnostics PCR Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Clinical Diagnostics PCR Market Size and Growth
The Clinical Diagnostics PCR market is experiencing robust growth, driven by increased demand for rapid and accurate testing. The market is valued at approximately $7 billion in 2023, with a projected CAGR of over 9% through 2028. Key factors include technological advancements, rising infectious diseases, and expanding diagnostic applications.
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ Agilent Technologies Inc.
◍ Abbott
◍ Asuragen, Inc.
◍ Danaher
◍ Biocartis Group Nv
◍ Biomérieux
◍ Bio-Rad Laboratories, Inc.
◍ Genmark Diagnostics, Inc.
◍ Hologic, Inc.
◍ Luminex Corporation
◍ Meridian Bioscience, Inc.
◍ Qiagen N.V.
◍ Quantumdx Group
◍ Quidel, Inc.
◍ Roche
The Clinical Diagnostics PCR Market features key players like Abbott, Qiagen, and Roche. These companies drive growth through innovative PCR technologies, expanding testing capabilities, and enhancing disease detection accuracy. Their contributions include product development, strategic partnerships, and extensive market reach, fostering increased adoption and revenue generation in clinical diagnostics.
**Sales Revenue (approx.):**
- Abbott Laboratories: $43 billion
- Roche: $67 billion
- Qiagen: $1.9 billion
- Bio-Rad Laboratories: $3.4 billion
Request Sample Report
Market Segmentation
By Application
Hospitals
Clinics
Others
Request Sample Report
By Product
Infectious Disease
Cancer
Cardiovascular
Genetic
Others
Market Growth
Request Sample Report
$ X Billion USD
